Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers

NCT: NCT04794179 · COMPLETED

NCT IDNCT04794179
StatusCOMPLETED
Start Date2019-11-06
Completion2021-06-23

Brief Summary

The purpose of this study is to assess the effect of the Naida Link contralateral routing of signal (CROS) device on speech understanding in challenging listening situations and on the quality of life in unilateral CI recipients and their frequent communication partners. We hypothesize that: 1. Unilateral CI recipients will obtain higher speech understanding scores with the CROS device in challenging listening conditions 2. Use of the CROS device will lead to positive changes in ratings on Quality of Life measures for (i) unilateral CI recipients, and (ii) their frequent communication partners A frequent communication partner (FCP) is an individual (a family member, or a friend, or a care taker, or a significant other, or a colleague, etc.) who has at least two hours of in-person interactions with the CI recipient every week.

Frequently Asked Questions

What is CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers?

CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers is a clinical trial registered under NCT04794179. Current status: COMPLETED.

What is the status of NCT04794179?

The current status of NCT04794179 (CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers) is: COMPLETED.

When did CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers start?

CROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Givers started on 2019-11-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.